Ekso Bionics Holdings Inc
EKSO
Mkt cap
$42.05M
EV/Sales
0.51
P/E ratio
—
FY2026 Revenue
$71.60M
EPS (9mo ended 2025-09-30)
−$3.35
Gross Margin (FY2026)
−23.86%
Profit Margin (FY2026)
−70.28%
Beta
—
Div yield
—
Sector
Healthcare
EKSO at a glance
EKSO AI brief
AIOverview
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Analysts
RatingsQuant grade metrics
Sector-relative grades for valuation, growth, profitability, momentum and revisions
Financials
Earnings
Ownership
Insiders
Form 4 trades, last 90 days
Filings
Latest SEC filings
No recent SEC filings on file.
News
Latest stored headlines
EKSO — Ekso Bionics Holdings Inc · rev $71.6M
EKSO Key Statistics
- Market Cap: $42.0M
- P/B Ratio: 19.9
Ekso Bionics Holdings Inc (EKSO) is a medical instruments & supplies company listed on NASDAQ.
Latest reported EKSO revenue for 2026-05-31 was $71.6M. Net income was -$50.3M. Revenue was down 15.1% from 2025-05-31 to 2026-05-31. EKSO currently screens at market cap $42.0M.
Use this EKSO research hub for sector, financials, and filings — not a live tape.
Ekso Bionics Holdings Inc latest statements (FY2026)
Latest cached year on this hub. Full EKSO income, balance, and cash tables.
- Revenue$71.6M
- Net Income-$50.3M
- Total Assets$325.9M
- Total Debt$3.8M†
- Free Cash Flow$12.2M
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
EKSO FAQ
What industry is EKSO in?
Ekso Bionics Holdings Inc (EKSO) is a medical instruments & supplies company in the Healthcare sector.
What are EKSO's latest revenue and net income?
Latest cached Ekso Bionics Holdings Inc (EKSO) revenue for May 31, 2026 was $71.6M. Net income was -$50.3M. Statements: https://lician.com/financials/ekso
What is EKSO's market cap?
Ekso Bionics Holdings Inc (EKSO) market capitalization is $42.0M on the latest cached snapshot.